Clinical Trial Update: An Open Study of Tipepidine Hibenzate in Patients With Attention Deficit Hyperactivity Disorder (ADHD) [Phase 2]

View source ↗

Summary

Phase 2 open-study of Tipepidine Hibenzate in patients with attention-deficit/hyperactivity disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Tipepidine hibenzate (tipepidine hibenzate)

Snippet

Sponsor: Chiba University | Conditions: Attention Deficit Disorder With Hyperactivity | Phase 2 | Status: COMPLETED